Marchex (NASDAQ:MCHX – Get Free Report) is anticipated to issue its Q3 2026 results after the market closes on Tuesday, November 10th. Analysts expect Marchex to announce earnings of $0.04 per share and revenue of $16.24 million for the quarter. Parties may visit the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Tuesday, November 10, 2026 at 5:00 PM ET.
Marchex (NASDAQ:MCHX – Get Free Report) last released its earnings results on Wednesday, August 12th. The technology company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.02 by ($0.03). The business had revenue of $11.00 million for the quarter, compared to the consensus estimate of $11.20 million. Marchex had a negative net margin of 12.44% and a negative return on equity of 18.25%.
Marchex Price Performance
Shares of NASDAQ:MCHX opened at $1.32 on Monday. The stock has a market cap of $58.53 million, a PE ratio of -11.00 and a beta of 1.88. The company’s fifty day moving average is $1.39 and its 200 day moving average is $1.57. Marchex has a 52 week low of $1.15 and a 52 week high of $2.00.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Marchex in a research report on Thursday, October 15th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Marchex currently has a consensus rating of “Reduce”.
Check Out Our Latest Report on Marchex
Marchex Company Profile
Marchex, Inc is a conversational intelligence and analytics company that helps businesses understand and improve customer interactions. The company analyzes phone calls, text messages and other customer conversations to provide insights into marketing performance, sales effectiveness and service quality.
Its solutions include call tracking and attribution, conversation analytics, lead management and artificial intelligence-powered tools that identify customer intent, buying signals and opportunities for follow-up.
Read More
- Five stocks we like better than Marchex
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
- Anthropic’s S-1 Strengthens the Case for Broadcom’s AI Growth
- After the Midterms, Which of These 3 Defense ETFs Looks Strongest?
- The Ugly Truth Behind SoundHound’s Q3 Results
Receive News & Ratings for Marchex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marchex and related companies with MarketBeat.com's FREE daily email newsletter.
